These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12478115)

  • 1. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma.
    Sánchez-Ortiz RF; Huang WC; Mick R; Van Arsdalen KN; Wein AJ; Malkowicz SB
    J Urol; 2003 Jan; 169(1):110-5; discussion 115. PubMed ID: 12478115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M; Nitzke T; Helke C; Vogler H; Hoschke B
    Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage.
    Chang SS; Hassan JM; Cookson MS; Wells N; Smith JA
    J Urol; 2003 Oct; 170(4 Pt 1):1085-7. PubMed ID: 14501697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement.
    Pagano F; Bassi P; Ferrante GL; Piazza N; Abatangelo G; Pappagallo GL; Garbeglio A
    J Urol; 1996 Jan; 155(1):244-7. PubMed ID: 7490845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
    Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors.
    Türkölmez K; Tokgöz H; Reşorlu B; Köse K; Bedük Y
    Urology; 2007 Sep; 70(3):477-81. PubMed ID: 17905100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy.
    Muppa P; Gupta S; Frank I; Boorjian SA; Karnes RJ; Thompson RH; Thapa P; Tarrell RF; Herrera Hernandez LP; Jimenez RE; Cheville JC
    Pathology; 2017 Apr; 49(3):259-266. PubMed ID: 28259358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.
    Herr HW; Bochner BH; Dalbagni G; Donat SM; Reuter VE; Bajorin DF
    J Urol; 2002 Mar; 167(3):1295-8. PubMed ID: 11832716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases.
    Njinou Ngninkeu B; Lorge F; Moulin P; Jamart J; Van Cangh PJ
    J Urol; 2003 Jan; 169(1):149-52. PubMed ID: 12478124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?
    Kotb AF; Kovac E; Kassouf W; Chin J; Fradet Y; Izawa J; Estey E; Fairey A; Rendon R; Cagiannos I; Lacombe L; Lattouf JB; Bell D; Drachenberg D; Aprikian AG
    World J Urol; 2012 Dec; 30(6):761-7. PubMed ID: 22293934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
    Salama A; Abdelmaksoud AM; Shawki A; Abdelbary A; Aboulkassem H
    Clin Genitourin Cancer; 2016 Feb; 14(1):e43-7. PubMed ID: 26363827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
    Rogers CG; Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Lotan Y; Gupta A; Vazina A; Gilad A; Sagalowsky AI; Lerner SP; Schoenberg MP
    J Urol; 2006 Jun; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.